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We pursued several strategies for expressing either full-length Sus scrofa diacylglycerol kinase (DGK) alpha
or the catalytic domain (alphacat) in Escherichia coli. Alphacat could be extracted, refolded, and purified
from inclusion bodies, but when subjected to analytical gel filtration chromatography, it elutes in the void
volume, in what we conclude are microscopic aggregates unsuitable for x-ray crystallography. Adding
glutathione S-transferase, thioredoxin, or maltose binding protein as N-terminal fusion tags did not
improve alphacat’s solubility. Coexpressing with bacterial chaperones increased the yield of alphacat in the
supernatant after high-speed centrifugation, but the protein still elutes in the void upon analytical gel
filtration chromatography. We believe our work will be of interest to those interested in the structure of
eukaryotic DGKs, so that they know which expression strategies have already been tried, as well as to those
interested in protein folding and those interested in chaperone/target-protein interactions.
D
iacylglycerol kinases (DGKs) are a family of enzymes in eukaryotes that catalyze the transfer of the c-
phosphoryl from adenosine triphosphate (ATP) onto the hydroxyl of diacylglycerol to produce adenosine
diphosphate (ADP) and phosphatidic acid. Most mammalian DGKs are interfacial enzymes, catalyzing
reactions at the two-dimensional interface between the membrane and the aqueous phase.
Eukaryotic DGKs have been implicated in a number of physiological roles and human diseases1,2.
Understanding the structure of these enzymes would bring insight into their activity, open doors to DGK
modulator production and impact not only lipid signaling research but also medicine. Furthermore, little is
known about the function of lipid kinases. Unlike their relatives with soluble substrates, the interfacial properties
of these kinases greatly increase the technical difficulty for research. Lessons learned from DGKs might be applied
to other lipid kinases, or indeed other interfacial enzymes. Most research to date revolves around protein-protein
interactions, whereas much less concentrates on activity between lipids and proteins. Purification techniques and
structural studies between DGKs interactions with DAG may be applied to other proteins that interact with lipids.
Applications for this research are endless: not only could de novo protein lipid interactions be developed, but also
improvements to drug delivery systems would further advance medicine into a new era.
Most work on eukaryotic DGKs has been conducted on those isolated from endogenous sources. Eukaryotic
DGKs have been partially purified from rat liver3, rat brain4–6, bovine brain7, bovine thymus8, human platelets9,
porcine brain5, porcine testis10,11, porcine submaxillary glands12,13, baboon brain14, 3T3 mouse fibroblast
cells5,12,13,15–18, Drosophila heads19, and Caltharanthus roseus suspension-cultured cells20, and they have been
purified to apparent homogeneity from porcine brain21–23, porcine thymus12,13,16,24–26, bovine brain27, bovine
testis12,13,15,16, rat brain28–30, human platelets9, human white blood cells31, and Microsporum gypseum suspen-
sion-cultured cells32. While purified DGKs from endogenous sources have been invaluable for studying their
enzymology, these sources are not amenable to producing enough protein for pursuing structural studies.
Recombinant forms of eukaryotic DGKs have been expressed in E. coli33,34, in COS-7 cells33,35,36, in COS-1
monkey kidney cells12,13, in Jurkat human T cells35,37, in HEK293 human embryonic kidney cells35,38, and in Sf21
Spodoptera frugiperda cells39,40 and have been partially purified from HEK293 cells41, COS-7 cells42, Dictyostelium
discoideum43,44, E. coli41,45–49, and Sf21 cells50. In only two cases to our knowledge has a eukaryotic DGK been
purified to apparent homogeneity from a recombinant source: porcine DGK alpha was purified to apparent
homogeneity after being expressed in the Saccharomyces cerevisiae strain WY29412, and human DGK theta was
purified to apparent homogeneity after being expressed in HEK293 cells51. Truncations of the accessory (not
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As such, little is known about the structure of DGKs, particularly
of the catalytic domain. The catalytic domain is so-called because it is
a region of primary sequence homology that makes up the gene
family. Furthermore, this domain from S. scrofa DGK alpha, when
expressed in COS-7 cells, was reported to be catalytically compet-
ent42, possessing similar enzymatic properties to the full-length
enzyme, demonstrating that all of the determinants for the catalytic
reaction, including binding sites for the two substrates, are located in
this region of the protein. But whereas a nuclear magnetic resonance
(NMR) structure of the N-terminus of Homo sapiens DGK alpha has
been reported53, as have an NMR structure of the second C1
domain54 and an x-ray crystal structure of the SAM domain from
H. sapiens DGK delta55, no structures of any part of the catalytic
domain from any eukaryotic DGK have yet been published.
We therefore set out to express the catalytic domain of a eukaryotic
DGK. Our approach was to express either full-length or just the
catalytic domain of S. scrofa DGK-alpha (the best-studied of the
eukaryotic DGKs) in E. coli with the purpose of producing large
amounts of soluble protein for structural studies.
Results
pT71myc. Cloning, expression, refolding, purification, and analytical
gel filtration of alphacat in pT71myc. The alphacat construct consists
of residues 333–733 of S. scrofa DGK alpha, and is so named because
it includes the catalytic domain, which is annotated on the Conserved
Domain Database56 as LCB5. The missing N-terminal residues
include the EF-hand motifs and C1 domains; alphacat lacks the C-
terminal cysteine (Figure 1a). This construct was cloned into
pT71myc, which adds to the N-terminus of the protein a fusion
tag consisting of hexahistidine, a thrombin proteolytic site, a myc
tag, and a Tobacco Etch Virus (TEV) protease site. The total mass of
this protein construct (including the fusion tag) predicted to be
49.8 kD, and the isoelectric point (pI) is 6.99.
Expression of alphacat in the RosettaTM(DE3) (NovagenH) strain
of E. coli was induced by adding isopropyl-b-D-thiogalactopyrano-
side (IPTG). When compared to uninduced control, the induced
lysate expressed an additional band, easily detectable by Coomassie
staining, that migrates between the 40 kD and 50 kD molecular
weight standards during sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE), consistent with the predicted size of
the fusion protein of 49.8 kD. This band was also recognized by an
anti(a)-histidine antibody on immunoblots (Figure 1b), consistent
with its expressing the epitope tag.
The alphacat in pT71myc construct, however, produced mostly
insoluble protein: when the bacterial lysate was centrifuged, most of
the protein remained in the pellet and was not observed in the super-
natant (Figure 1c). When washed with 2 M urea and 2% (v/v) Triton
X-100, the vast majority of alphacat remained in the pellet rather
than the supernatant, leading us to conclude that the expressed pro-
tein went into inclusion bodies57. Alphacat could be extracted from
inclusion bodies using 6.8 M guanidinium chloride, and refolded by
snap-diluting fiftyfold into ice-cold buffer (Figure 1d). This refolded
alphacat could then be recovered from the supernatant after high-
speed centrifugation. This supernatant could be purified by nickel-
nitriloacetic acid (Ni-NTA) chromatography (Figure 1d).
Because monodispersity is considered a valuable quality of pro-
teins expressed for structural studies, the affinity-purified fraction
was subjected to analytical gel filtration. If the protein is monodis-
perse, it will elute as a single peak at the appropriate molecular
weight: for alphacat in pT71myc, this would be at 49.8 kD (between
the 29 kD carbonic anhydrase and the 66 kD albumin molecular
weight standards) if it is a monomer, at 99.6 kD (between albumin
and the 150 kD alcohol dehydrogenase) if it is a dimer, etc. Although
refolded purified alphacat was recovered from the supernatant after
centrifugation, when subjected to SephadexH G-200 gel filtration
chromatography, the protein eluted in the void volume (Figure 1e).
Cloning, expression, purification, and analytical gel filtration of
alphacat in pT71myc coexpressed with bacterial chaperones.
Coexpression with bacterial chaperones is a commonly used strategy
to improve the yield and solubility of recombinantly expressed pro-
teins in E. coli58–60. In an attempt to improve the solubility of alphacat,
we therefore coexpressed it with each of five sets of bacterial chaper-
ones: GroEL/ES, Trigger Factor (TF), GroEL/ES/TF, DnaK/DnaJ/
GrpE, and DnaK/DnaJ/GrpE/ClpB. The molecular weights of the
bacterial chaperones are as follows: GroEL 5 57.4 kD; GroES 5
10.4 kD; TF 5 48.2 kD; DnaK 5 69.1 kD; DnaJ 5 41.1 kD; GrpE
5 21.8 kD; ClpB 5 95.9 kD.
The RosettaTM(DE3) strain of E. coli, which had been used to
express the alphacat in pT71myc above, contains pRARE, a plasmid
encoding the tRNAs for codons that are commonly used by eukar-
yotes but rarely used by E. coli. pRARE, however, contains the same
antibiotic resistance gene as the plasmid encoding the chaperones,
therefore to be able to select for expression of the chaperones, we
switched to the BL21(DE3) strain of E. coli. Alphacat coexpressed
with GroEL, GroES, TF, and DnaK robustly expressed when induced
with IPTG, as detected by Coomassie staining after SDS-PAGE
(Figure 2a). DnaJ, GrpE, and ClpB expression were not detectable
by Coomassie staining.
To identify which chaperone constructs enhanced solubility of
alphacat, they were coexpressed either at 37uC for three hours, or
at 16uC overnight. Coexpression of either GroEL/ES or GroEL/ES/
TF at 16uC overnight, and to a lesser extent, coexpression of GroEL/
ES/TF at 37uC for three hours, resulted in an increase in alphacat
detected in the supernatant following centrifugation of the lysate
(Figure 2a).
As can be seen in Figure 2a, in addition to the alphacat band, the a-
DGK-alpha antibody recognizes higher-molecular weight bands (in
addition to the alphacat band) in the GroEL-containing lanes of the
immunoblots. Because the a-DGK-alpha antibody recognizes GroEL
(Figure 2b), we concluded that the 60 kD bands in the immunoblot
in Figure 2a are GroEL.
Alphacat coexpressed with GroEL/ES at 16uC overnight was par-
tially purified by Ni-NTA chromatography, and GroEL (the upper
band) coeluted with alphacat (the lower band) from the Ni-NTA
resin (Figure 2c). When the Ni-NTA eluate was subjected to
SephadexH G-200 size-exclusion chromatography, alphacat and
GroEL coeluted in the void volume (Figure 2d).
If the GroEL/ES complex had never released alphacat, it would be
predicted to form a complex made of fourteen GroEL monomers and
seven GroES monomers, plus the alphacat, at least 920 kD in size,
indeed larger than the ,200-kD void volume of the SephadexH G-
200 resin. 1 mM ATP has been reported to be sufficient to cause
GroEL to release its substrates61. To test whether 1 mM ATP would
cause GroEL to release alphacat, we lysed and purified alphacat from
the co-expressing lysates in the presence of 1 mM ATP. 1 mM ATP
has no effect on the Ni-NTA purification of alphacat and GroEL/ES,
and GroEL continued to coelute with alphacat from the Ni-NTA
resin (Figure 2e).
Cloning and expression of full-length DGK alpha in pT71myc. The
cDNA for full-length S. scrofa DGK alpha (amino acids 1-734) was
cloned into the pT71myc vector, adding the same N-terminal fusion
tag as described above for the alphacat construct, consisting of a
hexahistidine, a thrombin proteolytic site, a myc tag, and a TEV
protease site (Figure 3a). The total mass of this protein construct
(including the fusion tag) and the pI are predicted to be 87.5 kD
and 6.10 respectively.
When full-length DGK alpha in pT71myc is transformed into the
BL21(DE3) strain of E. coli, it expresses readily after induction with
IPTG, producing a band, easily detectable by Coomassie staining
after SDS-PAGE, that migrates between the 70 kD and 100 kD mole-
cular weight markers, consistent with the predicted size of 87.5 kD,
and is recognized by an a-histidine antibody on immunoblots
www.nature.com/scientificreports
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Figure 1 | Cloning, expression, refolding, purification, and analytical gel filtration of alphacat in pT71myc. (a) Top, a schematic of S. scrofa
DGK alpha. Middle, a schematic of ‘‘alphacat’’, which consists of residues 333–733 of DGK alpha, including the LCB5 domain, but missing the C-terminal
cysteine. Bottom, a magnification of the epitope tag region of alphacat in pT71myc. pT71myc adds to the N-terminus of the protein a fusion tag consisting
of a hexahistidine, a thrombin proteolytic site, a myc tag, and a TEV protease site. The total mass of this protein construct (including the fusion tag)
and pI are predicted to be 49.8 kD and 6.99, respectively. (b) SDS-PAGE of 12% acrylamide gels followed by: left, Coomassie staining; right, immunoblot
against histidine. IB, immunoblot. (c) SDS-PAGE of a 12% acrylamide gel followed by Coomassie staining. DNAse I was added to the lysate to
10 U per mL. TX-100, Triton X-100. (d) SDS-PAGE of 12% acrylamide gels followed by: top, Coomassie staining; bottom, immunoblot against DGK
alpha C-terminus. (e) Elution volumes of molecular weight standards and of purified alphacat from a SephadexH G-200 column. Left vertical axis, the
absorbance at 620 nm (A620) of blue dextran elution and the absorbance at 280 nm (A280) of protein standard elutions. Right vertical axis, protein
concentration of eluted alphacat, as measured by the Bio-Rad Protein Assay.
www.nature.com/scientificreports
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Figure 2 | Expression, purification, and analytical gel filtration of alphacat in pT71myc coexpressed with bacterial chaperones. (a) SDS-PAGE of 12%
acrylamide gels followed by: left, Coomassie staining; right, immunoblot against DGK alpha C-terminus; top, induced at 37uC for three hours; bottom,
induced at 16uC overnight. U, uninduced; L, lysate; S, supernatant (after removing insoluble from lysate). (b) SDS-PAGE of an 8% acrylamide gel
followed by immunoblotting against DGK alpha C-terminus. (c) SDS-PAGE of a 10% acrylamide gel followed by Coomassie staining. (d) Top, elution
volumes of molecular weight standards and of purified alphacat from a SephadexH G-200 column. Left vertical axis, A620 of blue dextran elution and
A280 of protein standard elutions. Right vertical axis, quantification of the immunoblot signal from the blot shown at bottom, mean 6 standard deviation
(SD) (arbitrary units (AU)). Densitometry of the ,50 kD band was measured three times from the same film using ImageJ. Bottom, SDS-PAGE of a 10%
acrylamide gel followed by immunoblotting against DGK alpha C-terminus. (e) SDS-PAGE of a 10% acrylamide gel followed by Coomassie staining. The
lanes marked ‘‘1’’ were purified in the presence of 1 mM ATP.
www.nature.com/scientificreports
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(Figure 3b), consistent with its expressing the epitope tag, as
expected. This construct, however, like alphacat in pT71myc, also
produces insoluble protein: when the bacterial lysate is centrifuged,
the protein remains in the pellet.
In order to determine whether any of the sets of chaperones could
improve this construct’s solubility, DGK alpha in pT71myc and each
of the sets of chaperones were coexpressed either at 37uC for three
hours, or at 16uC overnight. At 16uC, co-expression of each of the sets
of plasmids increased the amount DGK alpha detected in the super-
natant after centrifugation (Figure 3b). The set that increased the
amount to the greatest extent was GroEL/ES/TF, but even in this
case, most of the protein remains in the pellet (Figure 3b).
Cloning, expression, purification and analytical gel filtration of alpha-
cat in pGEX-4T2 coexpressed with bacterial chaperones. Translational
folding partners have been reported to improve the solubility of
proteins expressed in E. coli62–65. In addition to being a useful epitope
tag for affinity purification66, glutathione-S-transferase (GST) is one
such fusion tag that has been reported to improve the solubility of
target proteins to which it has been fused67. In fact, GST fusion tags
have been successfully used to express the EF-hands of DGK alpha
and gamma (although not beta) in E. coli52. In an attempt to improve
the solubility of recombinantly expressed alphacat, we therefore
cloned alphacat into the pGEX-4T2 vector (Figure 4a). This vector
introduces GST from Schistosoma japonicum followed by a
Figure 3 | Cloning and expression of full-length DGK alpha in pT71myc. (a) Top, schematic of full-length S. scrofa DGK alpha in pT71myc.
Bottom, a magnification of the epitope tag region of alpha in pT71myc. pT71myc adds to the N-terminus of the protein a fusion tag consisting of a
hexahistidine, a thrombin proteolytic site, a myc tag, and a TEV protease site. The total mass of this protein construct (including the fusion tag) and pI are
predicted to be 87.5 kD and 6.10, respectively. The epitope-tagged region of the construct is magnified for clarity. (b) SDS-PAGE of 8% acrylamide gels
followed by: left, Coomassie staining; right, immunoblotting against hexahistidine; top, induced at 37uC for three hours; bottom, induced at 16uC
overnight. L, lysate; S, supernatant (after removing insoluble from lysate).
www.nature.com/scientificreports
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thrombin proteolytic site at the N-terminus of the protein. The
total mass of this protein construct (including the fusion tag) and
pI are predicted to be 71.6 kD and 6.97, respectively. DNA sequen-
cing confirmed the proper leader sequence, including the entire
GST gene and the thrombin proteolytic site, and the insertion of
alphacat.
When alphacat in pGEX-4T2 was transformed into BL21 (DE3)
strain of E. coli, it expressed readily after induction with IPTG, pro-
ducing a band, easily detectable by Coomassie staining after SDS-
PAGE, that runs between the 60 kD and 70 kD molecular weight
markers, slightly faster than its predicted size of 71.6 kD, and
was recognized by an a-DGK-alpha antibody by immunoblot
Figure 4 | Cloning, expression, purification, and analytical gel filtration of alphacat in pGEX-4T2 coexpressed with bacterial chaperones.
(a) ‘‘Alphacat’’ consists of residues 333–733 of S. scrofa DGK alpha. pGEX-4T2 adds to the N-terminus of the protein a fusion tag consisting of S.
japonicum GST followed by a thrombin proteolytic site. The total mass of this protein construct (including the fusion tag) and pI are predicted to be
71.6 kD and 6.97, respectively. (b) SDS-PAGE of 12% acrylamide gels followed by: left, Coomassie staining; right, immunoblotting against against DGK
alpha C-terminus. I, induced; U, uninduced; L, lysate; S, supernatant (after removing insoluble from lysate). (c) SDS-PAGE of a 10% acrylamide gel
followed by Coomassie staining. This sample was purified after having previously flowed through MagneGSTTM. The insoluble fraction was removed
before loading onto fresh MagneGSTTM. GSH, glutathione. (d) Elution volumes of molecular weight standards and of purified alphacat from a SephadexH
G-200 column. Left vertical axis, A620 of blue dextran elution and A280 of protein standard elutions. Right vertical axis, quantification of the
immunoblot signal from the blot shown at right, mean 6 SD (AU). Densitometry of the ,70 kD band was measured three times from the same film using
ImageJ. Right, SDS-PAGE of an 8% acrylamide gel followed by immunoblotting against DGK alpha C-terminus.
www.nature.com/scientificreports
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(Figure 4b). As we observed with alphacat in pT71myc, the alphacat
in pGEX-4T2 construct produced insoluble protein, as measured by
detection either by Coomassie staining or immunoblot following
SDS-PAGE following whole lysate centrifugation. As we also
observed with alphacat in pT71myc, coexpressing GroEL/ES
increased the amount of GST-tagged alphacat detected (either by
Coomassie or immunoblot) in the supernatant after centrifugation.
(As above, GroEL is recognized by the a-DGK-alpha antibody; in
this case, GroEL is the lower band, and alphacat is the upper band.)
Alphacat in pGEX-4T2 coexpressed with GroEL/ES could be par-
tially purified by affinity chromatography, but, once again, as with
alphacat in pT71myc, GroEL coeluted with alphacat from the
glutathione particles (Figure 4c). When the eluate was subjected to
SephadexH G-200 analytical gel filtration chromatography, the two
proteins coeluted in the void volume (Figure 4d).
Cloning and expression of alphacat and full-length DGK alpha in
pET32a coexpressed with bacterial chaperones. In another attempt
to improve the solubility of alphacat and full-length DGK alpha,
these proteins were each cloned into the plasmid pET32a, which adds
to the N-terminus of the protein a fusion tag consisting of E. coli
thioredoxin (TRX), which has been reported to improve the solubil-
ity of target proteins62,68. This plasmid also adds to the N-terminus
hexahistidine, which can be used for affinity purification (Figure 5a).
We also added either a TEV protease site or a PreScission Protease
site, which could be used to proteolytically remove the fusion tag, and
named the constructs accordingly (alphacat TEV in pET32a, alpha-
cat PP in pET32a, and full-length alpha TEV in pET32a). While
cloning, we also took the opportunity to add back the 734th residue,
a cysteine, to the C-terminus of alphacat, and to remove the initial
methionine from full-length DGK alpha. The total mass of the alpha-
cat construct (including the fusion tag, and with either protease site)
is predicted to be 64.4 kD, and the pI is predicted to be 6.19. The total
mass and pI of the full-length DGK alpha construct are predicted to
be 102.0 kD and 5.84, respectively.
When these pET32a constructs were transformed into the
BL21(DE3) strain of E. coli, they each expressed readily after induc-
tion with IPTG, producing a band that runs at the predicted size,
which was easily detectable by Coomassie staining after SDS-PAGE
(Figure 5b, top left). As we observed with our other constructs, the
TRX-tagged alphacat and full-length DGK alpha constructs pro-
duced insoluble protein, as measured by detection by Coomassie
staining after SDS-PAGE in the supernatant after centrifugation.
To determine whether coexpression with bacterial chaperones
improves the solubility of these constructs, we coexpressed each of
the three pET32a constructs with GroEL/ES, as well as alphacat TEV
with each of the five sets of chaperones. Unlike alphacat in pT71myc
or alphacat in pGEX-4T2, coexpressing with chaperones did not
improve the solubility of either alphacat or full-length DGK alpha
in pET32a, as measured by Coomassie staining or immunoblotting
following SDS-PAGE following centrifugation (Figure 5b, right).
Once again, GroEL is recognized by the a-DGK-alpha antibody; in
this case, GroEL is the lower band, and alphacat is the upper band.
GroEL is soluble after centrifugation, whereas alphacat TEV in
pET32a is not.
Cloning, expression, purification, and analytical gel filtration of
alphacat and full-length DGK alpha in pET28-HisMBP-FLAGpp.
Maltose binding protein (MBP) has been reported to improve the
solubility of target proteins to which it has been fused63,69,70. We
cloned both alphacat and full-length DGK alpha into the pET28-
HisMBP-FLAGpp plasmid, which adds to the N-terminus of the
protein a fusion tag that includes hexahistidine, Pyrococcus furiosus
MBP, a FLAG tag, and a PreScission Protease site (Figure 6a). As with
pET32a, we took the opportunity while cloning to add back the 734th
residue, a cysteine, to the C-terminus of alphacat, and to remove the
initial methionine from full-length DGK alpha. The total mass and pI
of the alphacat and full-length DGK alpha constructs are predicted to
be 92.8 kD, 5.51, 130.6 kD, and 5.45, respectively.
When MBP-tagged alphacat or full-length DGK alpha was trans-
formed into the BL21(DE3) strain of E. coli, they each expressed
readily after induction with IPTG, producing a band, easily detect-
able by Coomassie staining following SDS-PAGE, of the predicted
size that is recognized by thea-DGK-alpha antibody (Figure 6b). The
MBP tag does not appear to improve DGK alpha’s solubility: the
fusion-tagged protein, either alphacat or full-length DGK alpha,
while easily detectable in the lysate, remains undetectable in the
supernatant by immunoblotting after centrifugation.
For our pT71myc construct, we had observed that although most
of the expressed alphacat was in the pellet, the very small amount in
the supernatant, even of low enough levels to be undetectable by
immunoblotting, could be enriched by affinity purification on Ni-
NTA (unpublished observations, EP). We therefore attempted to
likewise purify the supernatant of MBP-tagged alphacat by Ni-
NTA affinity chromatography to see whether enough alphacat could
be enriched to subject to analytical gel filtration chromatography.
MBP-tagged alphacat could indeed be enriched by Ni-NTA chro-
matography (Figure 6c). When the eluate was subjected to
SephadexH G-200 analytical gel filtration chromatography, however,
MBP-tagged alphacat eluted in the void volume (Figure 6d), as we
had observed with our other constructs.
In another attempt to improve our protein constructs’ solubility,
after inducing expression in E. coli with IPTG we added chlor-
amphenicol to arrest translation, which has been reported in to
improve the solubility of other proteins prone to aggregation71.
Treating the cells with chloramphenicol did not appear to improve
the recovery of MBP-tagged alphacat or full-length DGK alpha in the
supernatant following centrifugation, as measured by either
Coomassie staining or immunoblotting following SDS-PAGE
(Figure 6e).
Discussion
For all of the constructs tested, when either full-length S. scrofa DGK
alpha or just its catalytic domain is expressed in E. coli, the recom-
binant protein is insoluble. Alphacat can be refolded from inclusion
bodies, but while it is detectable in the supernatant after high-speed
ultracentrifugation, when this soluble fraction is subjected to analyt-
ical gel filtration chromatography, alphacat elutes in the void volume.
We therefore conclude that the alphacat is forming aggregates
unsuitable for pursuit for structural studies.
An alternative explanation is that the alphacat oligomerizes into a
complex large enough to elute in the void volume of the SephadexH
G-200 resin. Oligomerization of LCB5 family proteins is not unpre-
cedented: purified Salmonella typhimurium YegS recombinantly
expressed in E. coli elutes as a dimer from a Superdex G200 resin72,
E. coli YegS73 and Staphylococcus aureus DgkB74 recombinantly
expressed in E. coli each crystallize as dimers, and H. sapiens DGK
epsilon recombinantly expressed in COS-7 cells has been reported to
dimerize based on its migration in perfluorooctanoic acid (PFO)-
PAGE40. The smallest of the constructs studied in this report is
alphacat in pT71myc, with a molecular weight of 49.8 kD. In order
for oligomerized alphacat in pT71myc to be larger than b-amylase
(200 kD), in front of which we observe it to elute from the SephadexH
G-200 resin, its oligomerization state would have to be at least that of
a pentamer (249 kD). Because the most plausible oligomerization
states of alphacat would be either a dimer or else a dimer of dimers,
we find the microscopic aggregate hypothesis more convincing.
Solubility challenges with expressing eukaryotic DGKs recombi-
nantly in E. coli have been previously reported. In one case S. scrofa
DGK alpha purified from inclusion bodies had no detectable DGK
activity46 (even though E. coli lysate overexpressing the same protein
does have DGK activity33); in another, AtDGK2 from Arabidopsis
thaliana required a NusA tag in order to express in E. coli48.
www.nature.com/scientificreports
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Takahashi et al. report that they were unable to express the C-ter-
minal domain of S. scrofa DGK alpha in E. coli because the cysteine-
rich C1 domain rendered it insoluble36. Recombinantly expressing
LCB5 family proteins in E. coli has generally been more successful
when those family members are prokaryotic72–74.
One possible explanation for why recombinant expression of pro-
karyotic LCB5 family proteins has been more successful than eukar-
yotic is that prokaryotes have different codon abundances than
eukaryotes. Insufficient availability of the appropriate tRNA can lead
to ribosome pausing, frameshifts, deletions, mistranslations, aborted
Figure 5 | Cloning and expression of alphacat and full-length DGK alpha in pET32a coexpressed with bacterial chaperones. (a) Top: schematic of
alphacat TEV in pET32a construct. ‘‘Alphacat’’ consists of residues 333–733 of S. scrofa DGK alpha; for this construct, the 734th residue of S. scrofa DGK
alpha, cysteine, was added back. pET32a adds to the N-terminus of the protein a fusion tag consisting of E. coli TRX followed by a hexahistidine tag. For
alphacat TEV, a TEV protease site site was added between the fusion tag and alphacat. The total mass of this protein construct (including the fusion tag)
and pI are predicted to be 64.4 kD and 6.19, respectively. Middle: schematic of alphacat PP in pET32a construct. Instead of a TEV protease site, a
PreScission Protease site was added between the fusion tag and alphacat. The total mass of this protein construct (including the fusion tag) and pI are
predicted to be 64.4 kD and 6.19, respectively. Bottom: schematic of full-length S. scrofa DGK alpha TEV in pET32a construct. A TEV protease site was
added between the fusion tag and DGK alpha, and the initial methionine was removed from DGK alpha. The total mass of this protein construct
(including the fusion tag) and pI are predicted to be 102.0 kD and 5.84, respectively. (b) SDS-PAGE of 10% acrylamide gels followed by: top and middle,
Coomassie staining; bottom, immunoblot against DGK alpha C-terminus. L, lysate; S, supernatant (after removing insoluble from lysate).
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Figure 6 | Cloning, expression, partial purification, and analytical gel filtration of alphacat and full-length DGK alpha in pET28-HisMBP-FLAGpp.
(a) Top, schematic of alphacat in HisMBP-FLAGpp construct. ‘‘Alphacat’’ consists of residues 333–733 of S. scrofa DGK alpha; for this construct,
the 734th residue of S. scrofa DGK alpha, cysteine, was added back. pET28-HisMBP-FLAGpp adds to the N-terminus of the protein a fusion tag consisting
of a hexahistidine tag, followed by P. furiosus maltose-binding protein (MBP) fusion tag, followed by a FLAG tag, followed by a PreScission Protease site.
The total mass of the protein construct (including the fusion tag) and pI are predicted to be 92.8 kD and 5.51, respectively. Bottom, schematic of full-
length S. scrofa DGK alpha construct. The total mass of the protein construct (including the fusion tag) and pI are predicted to be 130.6 kD and 5.45,
respectively. (b) SDS-PAGE of 8% acrylamide gels followed by: top, Coomassie staining; bottom, immunoblotting against DGK alpha C-terminus. U,
ininduced; I, induced; L, lysate; S, supernatant (after removing insoluble from lysate). (c) SDS-PAGE followed by: left, Coomassie staining; right,
immunoblotting against DGK alpha C-terminus. The soluble fraction after lysis (supernatant) had been stored for two weeks at 280uC (in 20% glycerol);
immediately prior to affinity purification, the insoluble fraction was removed by centrifugation at 100,000 3 g for one hour at 4uC (supernatant’s
supernatant). (d) Left, elution volumes of molecular weight standards and of purified alphacat from a SephadexH G-200 column. Left vertical axis, A620
of blue dextran elution and A280 of protein standard elutions. Right vertical axis, quantification of the immunoblot signal from the blot shown at right,
mean 6 SD (AU). Densitometry of the ,90 kD band was measured three times on the same film using ImageJ. Right, SDS-PAGE followed by
immunoblotting against DGK alpha C-terminus. (e) SDS-PAGE of 8% acrylamide gels followed by: top, Coomassie staining; bottom, immunoblotting
against DGK alpha C-terminus. U, uninduced; I, induced; L, lysate; S, supernatant (after removing insoluble from lysate). Cam, chloramphenicol.
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translation products, and decreased expression of the target protein,
even in response to only a single rare codon75,76. The cDNA of alpha-
cat does in fact have a number of rare codons: two AGG, five AGA,
eight CTA, one ATA, four CGA, twelve CCC, eight GGA, and three
CGG. Alphacat TEV in pET32a, when coexpressed with the DnaK/
DnaJ/GrpE/ClpB set of chaperones, produces, in addition to the
predominant band of the predicted size, an additional, lower band
that is recognized by the a-DGK-alpha-C-terminus antibody
(Figure 5b, bottom right); alphacat in pET28-HisMBP-FLAGpp
(Figure 6b) and alphacat in pT71myc (Figure 1b) likewise produce
several recognized bands. These additional bands could indeed be
truncations produced by aborted translation or by frameshifting
during translation.
Another possible explanation for the greater success for recom-
binant expression of prokaryotic LCB5 family proteins than of eukar-
yotic proteins is that eukaryotic proteins expressed in prokaryotic
systems may not be properly post-translationally modified.
Phosphorylation sites on DGK have been described24,77,78: these, or
other as-of-yet unannotated post-translational modifications, could
be important for protein solubility or stability.
Size may be another factor limiting the success of recombinantly
expressing eukaryotic DGKs in prokaryotic systems. S. typhimurium
YegS and S. aureus DgkB are 32 and 35 kD, respectively, smaller than
any of the eukaryotic DGKs. Although no absolute upper limit has
been reported for the size of proteins that can be recombinantly
expressed in E. coli, in general, larger proteins express less well.
Our own observations are consistent with this rule of thumb: our
the smallest construct tested, alphacat in pT71myc, expresses the
most robustly, and our alphacat constructs always express at higher
levels than their full-length DGK alpha counterparts.
Translational folding partners are frequently used to improve the
solubility of proteins expressed in E. coli62–65. However, our work has
demonstrated that adding GST, TRX, or MBP as a fusion tag did not
improve the solubility of either full-length DGK or alphacat. All of
the constructs in this study are tagged on the N-terminus. The posi-
tion of a fusion tag can greatly affect a protein’s expression and
function79,80; perhaps exposure of the N-terminus of full-length
DGK alpha is required for stability, and a C-terminally tagged con-
struct would express better or be more stable. Alternatively, as dis-
cussed above, even the smallest constructs used in this study is large
by prokaryotic standards, and perhaps any additional solubility con-
ferred by the fusion tag was counteracted by the fact that the tagged
protein was larger in size.
Progress is being made in the ability to predict the ideal fusion tag
to solubilize target proteins; however, much work remains to be
done. Protein solubility prediction servers81,82 are invaluable tools,
but they sometimes disagree in their predictions. For example,
PROSO82 predicts our full-length DGK alpha in pT71myc construct
to be soluble with a probability of 0.520, whereas SOLpro81 predicts it
to be insoluble with a probability of 0.550540. Their predictions may
not be always accurate, either: SOLpro81, for example, predicts the
alphacat in pET28-HisMBP-FLAGpp construct to be soluble with a
probability of 0.771506, which is contrary to the data we show in
Figure 6. Given the difficulty in predicting which solubility tags will
work, it is entirely possible that alternative solubility tags could help
increase the soluble yield of mammalian DGKs, and perhaps even
cause them to elute as a monodisperse population from an analytical
gel filtration column. As mentioned above, the NusA tag proved
helpful for expressing A. thaliana AtDGK2 in E. coli48; however, this
report does not mention whether the purified AtDGK2 was mono-
disperse. Solubility predictions by SOLpro81 for NusA-tagged alpha-
cat and full-length DGK alpha are very optimistic, predicting them to
be soluble with probabilities of 0.922228 and 0.870324, respectively,
whereas predictions by PROSO82 are more measured: 0.561 and
0.532, respectively, possibly owing to the large size of these constructs
(110 and 148 kD, respectively). Tags specifically engineered to
improve the solubility of target proteins have been successfully
developed in some systems65, and could be useful for DGK studies;
however, at this juncture, improving the solubility of eukaryotic
DGKs remains a process of trial-and-error.
Coexpressing alphacat with bacterial chaperones, especially
GroEL/ES, increases the yield of some, but not all, of our constructs
in the soluble fraction, which is promising for large-scale expressions
for crystallography. Unfortunately, alphacat in this soluble fraction
still elutes in the void volume during analytical gel filtration chro-
matography. One reason that alphacat coexpressed with GroEL/ES
elutes in the void volume could be explained by its being complexed
to the GroEL, based on our evidence that the two proteins copurify
on Ni-NTA, and they coelute from the analytical gel filtration col-
umn. If the alphacat is in fact complexed with GroEL/ES, the pre-
dicted molecular weight of the complex would be greater than
900 kD, and thus would indeed be predicted to elute in the void
on the SephadexH G-200 column. Another possibility is that while
coexpressing alphacat with bacterial chaperones is sufficient to
increase its yield in the supernatant, it still remains in microscopic
aggregates.
The maximum size of a protein to fit in the cis-cavity of GroEL has
been reported to be 57 kD83; on the other hand, GroEL has also been
reported to help fold substrates as large as 150 kD84. Therefore, it is
not entirely surprising that the GroEL/ES sets of chaperones did not
improve the solubility of any of the full-length DGK alpha con-
structs, or of the alphacat in pET32a constructs, although coexpres-
sion with GroEL/ES clearly improved the yield of alphacat in pGEX-
4T2 in the supernatant after centrifugation, even though the size of
the GST-tagged alphacat construct is 71.6 kD.
Analysis of the chaperone data is further complicated by the fact
that GroEL is recognized by the a-DGK-alpha antibody (Figure 2b).
Endogenous GroEL could thus be the identity of the predominant
60 kD immunoreactive band seen in the partially purified alphacat in
pET28-HisMBP-FLAGpp, in which case, GroEL’s failing to release
alphacat could once again explain why alphacat in pET28-HisMBP-
FLAGpp elutes in the void volume from the analytical gel filtra-
tion column, even though GroEL was not overexpressed in this
preparation.
It is not surprising that the DnaK/DnaJ/GrpE and DnaK/DnaJ/
GrpE/ClpB sets of chaperones did not improve the solubility of either
alphacat or full-length DGK alpha in any of the constructs tested,
seeing as only DnaK appears to overexpress (Figures 2a, 3b, 5b) and
its cochaperones DnaJ (which stimulates DnaK’s ATPase activity85)
and GrpE (which acts as a nucleotide exchange factor for DnaK85) are
not expressed proportionately. DnaK has also been reported to
induce proteolysis in response to overproduction of a recombinant
protein86, which may be the reason we observe new, smaller, immu-
noreactive bands in alphacat TEV in pET32a lysates when coex-
pressed with the DnaK set of chaperones (Figure 5b, bottom right).
It is entirely possible that coexpression with alternative sets of
chaperones could also enhance the solubility of these proteins, but
the process of choosing a set of chaperones to coexpress with a given
protein remains largely empirical. Other proteins reported to have
chaperone activity, and thus potential candidates for coexpression to
improve the solubility of eukaryotic DGKs, include Hsp9087, a-
crystallins88, and dehydrins89. DnaK itself indeed would also be a
candidate for consideration, as long as its cochaperones DnaJ and
GrpE are also appropriately expressed, and could even be coex-
pressed with GroEL/ES, given that these chaperones can work in
parallel90, thereby delivering the driving force needed to solubilize
DGK alpha.
Detergents have often been reported to improve the solubility of
recalcitrant proteins91–93. Our method for determining monodisper-
sity, analytical gel filtration using a SephadexH G-200 resin, however,
is incompatible with Triton X-100 concentrations as low as 0.01%
(v/v) because the detergent causes an unacceptable loss of resolution
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in the molecular weight standards (unpublished observations,
EP). Future studies wishing to monitor the monodispersity of eu-
karyotic DGKs may wish to consider alternative resin/detergent
combinations.
This body of work aims to provide valuable insight for those
wishing to express and purify eukaryotic DGK. By taking into
account all the aforementioned considerations, understanding a
complex protein like DGK alpha could open up doors for the puri-
fication and subsequent structural studies of other challenging pro-
teins and protein/lipid structures.
Methods
Cloning. The pT71myc plasmid was provided by Professor Daniel Leahy’s laboratory
(Biophysics and Biophysical Chemistry, The Johns Hopkins University School of
Medicine); the pET32a plasmid was provided by Professor Cynthia Wolberger’s
laboratory (Biophysics and Biophysical Chemistry, The Johns Hopkins University
School of Medicine); and the pET28-HisMBP-FLAGpp plasmid was provided by
Professor Sean Taverna’s laboratory (Pharmacology and Molecular Sciences, The
Johns Hopkins University School of Medicine). pT71myc is a derivative of the
pET28(a) vector; it uses the T7 promoter and contains the kanamycin resistance gene.
SalI and NotI sites, as well as desired protease sites, were added to the full-length
DGK alpha or alphacat inserts by the polymerase chain reaction (PCR). These SalI
and NotI sites were then used to clone the insert into the plasmid of interest.
Successful insertion was confirmed by DNA sequencing.
The chaperone-containing plasmids were provided by Professor Philip Cole’s
laboratory (Pharmacology and Molecular Sciences, The Johns Hopkins University
School of Medicine). The identity, insertion of the chaperones into the provided
plasmids, and sequence of the shorter chaperones (GroES and GrpE) were verified by
DNA sequencing (The Synthesis & Sequencing Facility, The Johns Hopkins
University School of Medicine). A protein-protein BLAST search94 identified GroEL
to be from either Plesiomonas shigelloides (GenBank: BAE95977.1) or E. coli (NCBI
Reference Sequence: YP_006093740.1) with at least two nonsynonymous point
mutations. GroES, TF, DnaK, GrpE, and ClpB were likewise identified to be from
E. coli (NCBI Reference Sequences NP_290775.1, NP_286178.1, NP_285706.1,
NP_417104.1, and NP_289147.1, respectively), and DnaJ to be from either E. coli
(NCBI Reference Sequence: NP_414556.1) or from Shigella flexneri (NCBI Reference
Sequence: NP_835756.1). Each chaperone plasmid included a chloramphenicol res-
istance gene, a T7 promoter, and the lac operator (LacO). In a single set, all the
chaperones are encoded in the plasmid in series (but each with their own stop codon)
behind a single promoter, with the exception of GroEL/ES/TF, in which case TF
follows a second copy of T7/LacO.
Protein expression. The BL21(DE3) or RosettaTM(DE3) (NovagenH) strains of E. coli
were transformed with the plasmid(s) of interest, and successful transformants were
selected on Luria Bertani (LB) agar (1.5% (w/v)) with the appropriate antibiotic
(kanamycin (30 mg/mL) for pT71myc and pET28-HisMBP-FLAGpp,
chloramphenicol (35 mg/mL) for the chaperones, and carbenicillin (100 mg/mL) for
pGEX-4T2 and pET32a). Either a single colony from a freshly grown LB agar plate, or
else a glycerol stock made from such a colony and then stored at 280uC, was used to
inoculate LB medium containing the appropriate antibiotic, and the culture was
shaken at 225 rotations per minute (rpm) overnight at 37uC. The following morning,
a larger culture was inoculated with the starter culture, and shaken at 37uC until the
OD600 reached 0.3–1, at which point IPTG was added to 0.1–1 mM to induce
expression of the plasmid. IPTG was omitted for uninduced controls. The cultures
were then shaken either at 37uC for three hours, or at 16uC overnight (12–22 hours).
The following morning, cells were pelleted by centrifugation (15 minutes at
,5000–20,000 3 g at 4uC). Cell pellets were resuspended in 4 mL lysis buffer per
gram cell pellet, except for full-length alpha and alphacat in pET32a, which were each
resuspended in 40 mL lysis buffer per gram cell pellet, and for full-length alpha in
pT71myc, which was resuspended in 0.25 mL lysis buffer per mL culture. For full-
length alpha and alphacat in pT71myc plus chaperones, in pET32a, and in pET28-
HisMBP-FLAPpp, this lysis buffer was 50 mM tris(hydroxymethyl)aminomethane
(Tris), pH 8.0, 300 mM NaCl, 10 mM imidazole, 5 mM MgCl2, 1 mM CaCl2, 0.25%
(v/v) Triton X-100, 13 protease inhibitor cocktail (Roche 11873580001), 0.5 mM
dithiothreitol (DTT); for alphacat in pT71myc without chaperones, this lysis buffer
was the same as above except that it was buffered to pH 6.4 with 50 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 0.5% (v/v) Nonidet P-
40 (NP-40) was used instead of Triton X-100; and for alphacat in pGEX-4T2, this lysis
buffer was 50 mM Tris, pH 8.0, 1 mM CaCl2, 0.25% (v/v) Triton X-100, 13 protease
inhibitor cocktail, 5 mM DTT. When time allowed, the resuspended cell pellet was
frozen at 280uC, and then rethawed to ensure complete lysis. Egg white lysozyme was
added to 1 mg per mL. The resuspended cell pellet was incubated on ice for thirty
minutes, vortexing occasionally to mix. The resuspended cell pellet was then lysed by
probe sonication in at least ten ten-second bursts, resting on ice between each burst,
until no longer viscous. The insoluble fraction was removed by centrifuging at
40,000–120,000 3 g for 65–90 minutes at 4uC.
Arresting protein translation. After expressing overnight at 20uC, E. coli cells were
pelleted by centrifugation. The samples annotated as ‘‘with Cam’’ in Figure 6e, both
uninduced and induced, were resuspended with LB plus kanamycin plus
chloramphenicol (200 mg/mL). Because our chloramphenicol stock solutions are
stored as 35 mg/mL in ethanol, ‘‘uninduced without Cam’’ samples were resuspended
in LB plus kanamycin plus ethanol (0.6% (v/v)) in order to control for the addition of
ethanol along with the chloramphenicol. ‘‘Induced without Cam’’ samples were
resuspended in LB plus kanamycin plus IPTG (0.1 mM). The cultures were shaken
for another two hours at 20uC, after which cell lysates were harvested as previously
described.
Refolding from inclusion bodies. The alphacat in pT1myc lysate was centrifuged at
,100,000 3 g for 45 minutes at 4uC. The pellet was resuspended in 2.5 mL per gram
cell pellet extraction buffer (50 mM HEPES, pH 6.4, 300 mM NaCl, 10 mM
imidazole, 5 mM MgCl2, 1 mM CaCl2, 6.8 M guanidinium chloride). To solubilize
alphacat from inclusion bodies, the resuspended pellet was probe-sonicated in ten-
second bursts, resting on ice between each burst, until clear. The insoluble fraction
was removed by centrifuging at ,100,000 3 g for 30 minutes at 4uC. The protein was
refolded by diluting 1550 (v/v) into loading buffer (50 mM HEPES, pH 6.4, 300 mM
NaCl, 10 mM imidazole, 5 mM MgCl2, 1 mM CaCl2, 0.5 mM DTT). The insoluble
fraction was removed by centrifuging ,20,000 3 g for 30 minutes at 4uC.
Batch purification: Ni-NTA. Alphacat in pT71myc and in pET28-HisMBP-
FLAGpp’s fusion tags included hexahistidine, which was used to purify the protein by
affinity chromatography to Ni-NTA agarose (QIAGENH 30210, which is a 50%
slurry). After removing the insoluble fraction from either the lysate or the refolded
protein, Ni-NTA agarose was directly added 1511-8000 (v/v), and incubated with the
protein (2 hours–3 days), rocking at 4uC. The resin was pelleted by centrifugation,
and the supernatant was collected as flowthrough. The resin was then washed, and
after each wash step, the resin was likewise collected by centrifugation. Purified
protein (eluate) was collected from the supernatant after incubating the resin with
elution buffer. For alphacat in pT71myc, the wash buffer was 50 mM HEPES, pH 6.4,
300 mM NaCl, 70 mM imidazole, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM tris(2-
carboxyethyl)phosphine (TCEP), and the elution buffer was the same except that the
imidazole was increased to 250 mM. For alphacat in pT71myc plus chaperones, wash
buffer 1 was 50 mM Tris, pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM CaCl2,
0.5 mM DTT; wash buffer 2 was the same except that it was buffered to pH 6.4 with
55 mM sodium citrate and also included 5 mM MgCl2; wash buffer 3 was the same as
wash buffer 2 except that imidazole was increased to 70 mM; elution buffer 1 had
250 mM imidazole; and elution buffer 2 had 500 mM imidazole. For alphacat in
pET28-HisMBP-FLAGpp, wash buffer 1 was the same as for alphacat in pT71myc
plus chaperones; wash buffer 2 was the same except that the imidazole was increased
to 70 mM; elution buffer 1 had 250 mM imidazole; and elution buffer 2 had 500 mM
imidazole.
Batch purification: Magne-GSTTM. Alphacat in pGEX-4T2’s fusion tags included
GST, which was used to purify the protein by affinity chromatography to Magne-
GSTTM glutathione particles (Promega V8611). Magne-GSTTM beads were prewashed
in wash buffer (50 mM Tris, pH 8.0, 140 mM NaCl, 10 mM KCl, 1 mM CaCl2, 0.25%
(v/v) Triton X-100, 13 protease inhibitor cocktail, 5 mM DTT). 46.9 mL washed
beads per gram cell pellet were added to the lysate after the insoluble fraction had been
removed, and rocked at 4uC for 75 minutes. The beads were pelleted by magnet, and
the supernatant was collected as flowthrough. The beads were washed with wash
buffer and then eluted with elution buffer 1 (the same as wash buffer, except with
0.1 mM glutathione), elution buffer 2 (0.3 mM glutathione), elution buffer 3
(0.5 mM glutathione), elution buffer 4 (1.5 mM glutathione), and elution buffer 5
(100 mM glutathione).
Analytical gel filtration. The analytical gel filtration resin used was SephadexH G-200
(Sigma G-200-120). All analytical gel filtration steps were carried out at 4uC. The resin
was hydrated in and equilibrated by gravity with gel filtration buffer. For alphacat in
pT71myc, the gel filtration buffer was 55 mM HEPES, 250 mM imidazole, 5 mM
MgCl2, 1 mM CaCl2, pH 6.4; for alphacat in pT71myc plus chaperones the gel
filtration buffer was the same except that it was buffered to pH 6.4 with 55 mM
sodium citrate; for alphacat in pGEX-4T2 plus chaperones the gel filtration buffer was
50 mM Tris, 100 mM KCl, pH 8.0; and for alphacat in pET28-HisMBP-FLAGpp the
gel filtration buffer was 50 mM Tris, 300 mM NaCl, 250 mM imidazole, 5 mM
MgCl2, 1 mM CaCl2, pH 8.0. The column was calibrated in each buffer system by
gravity flow with blue dextran (,2000 kD), sweet potato b-amylase (200 kD), yeast
alcohol dehydrogenase (150 kD), bovine serum albumin (66 kD), and/or bovine
erythrocyte carbonic anhydrase (29 kD). The void volume (Vo) was measured by
summing the volumes of the fractions up to and including the fraction with the
maximum absorbance at 620 nm. The elution volume (Ve) for each protein standard
was measured by summing the volumes of the fractions up to and including the
fraction with the maximum absorbance at 280 nm.
Before loading alphacat, the column was blocked with albumin (10 mg/mL, 1/20th
of the column bed volume), and then washed with two to three times the Ve of
albumin with gel filtration buffer. When necessary, prior to loading purified alphacat
was concentrated by dialyzing against dialysis buffer (gel filtration buffer plus 15%
(w/v) polyethylene glycol (PEG) 17.5 kD) using either a 10,000 molecular weight cut-
off (MWCO) cassette or 3.5 kD MWCO dialysis tubing. Immediately before loading,
the insoluble fraction of purified alphacat was removed by centrifuging at 40,000 3 g
for 90 minutes at 4uC. The soluble fraction was then loaded onto the gel filtration resin
(at a volume no greater than 1/20th the column bed volume). Fractions were collected,
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and the volume of each fraction was measured. In the case of alphacat in pT71myc,
the protein concentration of each fraction was measured by the Bio-Rad Protein
Assay (500-0006). In the case of alphacat in pT71myc plus chaperones, alphacat in
pGEX-4T2, and alphacat in PET28-HisMBP-FLAGpp, the fractions were analyzed by
immunoblotting to determine the elution volume.
SDS-PAGE. Because SDS precipitates with guanidine and with potassium, guanidine
and/or potassium was removed from guanidine or potassium-containing samples by
ethanol-precipitation and washing the protein pellet before combining with SDS gel-
loading-buffer.
Standard laboratory methods were used for protein electrophoresis. For immu-
noblotting, the primary antibodies used were, for Figure 1b, mouse a-His (Abcam
ab619695 (152500 (v/v))), for Figure 3, mouse a-His6 (Clontech 63121296 (155000
(v/v))), and for the other figures, rabbit a-DGK-alpha-C-term (Abgent AP8128b31
(15300 (v/v))).
Exposures faint enough that text could be read through the bands of interest were
selected for densitometry. Densitometry was measured by ImageJ (see ‘‘Equipment
and Settings’’).
Equipment and settings. The OdysseyH Infrared Imaging System running OdysseyH
v3.0 (LI-CORH) was used to scan the immunoblots shown in Figure 3. The
membranes were scanned with a resolution of 169 mm, quality of medium, offset of
0.0, and intensity of 5. The 700 channel is shown.
Film that had been exposed to immunoblots was scanned as 1200 dots per inch
(dpi) .tiff files. Densitometry of these files was measured by ImageJ97 (v1.46r) without
calibration, three times from the same film. The relative densitometry of each lane was
normalized to the total densitometry of all the lanes on that replicate. The means and
standard deviations (SigmaPlot 12) of three normalized densitometries for each lane
are displayed in the figures shown here.
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